Cryosite

Cryosite ensures secure cryogenic storage for cell and gene therapies in Australia, adhering to TGO 108 standards.

Cryosite highlights the role of cryogenic storage in supporting cell and gene therapies in Australia, focusing on compliance, safety, and scalability.

Cryosite provides compliant clinical trial supply logistics across Australia, emphasizing risk mitigation and timely delivery.

Cryosite offers tailored logistics solutions for clinical trials, ensuring compliance, timely delivery, and support.

Cryosite shares news, developments, and expert insights through blogs.

Cryosite maintains cold chain integrity and cryogenic storage reliability in Australia’s extreme climate using advanced infrastructure, monitoring, and compliance systems.

This blog explores the critical challenges in CAR-T cell therapy storage and explains Cryosite help bridge the gap between medical discovery and reliable patient treatment.

Cryosite helps sponsors strengthen clinical trial supply chains for 2026 through innovation, compliance, and cold chain logistics expertise in Australia.

Cryosite is an Australian leader in clinical trial logistics, offering expert management of temperature-sensitive supplies, storage, distribution, and reverse logistics.

Cryosite’s Board of Directors oversees corporate responsibility and governance to meet legal obligations and establish principles of corporate behavior.

If you need any information or requests related to clinical trial logistic services, we are ready to help you out. Call us at +61(2)88652000 to get a quote from us.

Cryosite answers common questions about clinical trial logistic services.

Cryosite specializes in clinical trial support, biologic storage, and cryogenic depot services in Australia.

Cryosite Limited expands its temperature-controlled storage and logistics services for life sciences clients. The company targets growth by addressing rising demand in biotech and medical research sectors. Cryosite operates under the **Research As A Service (RaaS)** model, offering scalable infrastructure for sensitive sample storage.

Jun 2026listcorp.comNews article

Cryosite, the blood bank operator, holds cash reserves exceeding its current market capitalization. The company’s financial strength highlights a significant disparity between its liquid assets and share valuation. Cryosite operates in the medical storage and distribution sector, focusing on preserving biological samples for research and clinical use.

Nov 2018StockheadNews article

Australia’s competition regulator, the ACCC, accuses Cryosite of violating merger laws by commencing operations before regulatory approval. The lawsuit targets Cryosite’s alleged ‘gun-jumping,’ a practice where companies act on proposed transactions prematurely. The ACCC claims this undermines fair competition and harms consumers by bypassing necessary oversight.

Jul 2018StockheadNews article

The Australian Competition and Consumer Commission (ACCC) has filed proceedings in the Federal Court against Cryosite Limited over alleged cartel behavior. The case involves an asset sale agreement between Cryosite and Cell Care Australia Pty Ltd (Cell Care).

Jul 2018Australian Competition and Consumer CommissionNews article